Blueprint Medicines Corporation (BPMC) Social Stream
BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BLUEPRINT MEDICINES CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 9 | $136 | $84 | $113.222 | $73.83 | 53.36% |
| 2021-11-10 | 9 | $136 | $84 | $114.444 | $73.83 | 55.01% |
| 2021-11-19 | 9 | $136 | $84 | $115.777 | $73.83 | 56.82% |
| 2021-11-29 | 9 | $136 | $84 | $115.555 | $73.83 | 56.51% |
| 2022-01-12 | 9 | $135 | $84 | $113.333 | $73.83 | 53.51% |
| 2022-01-25 | 9 | $135 | $84 | $110.555 | $73.83 | 49.74% |
| 2022-01-31 | 9 | $135 | $84 | $108.444 | $73.83 | 46.88% |
| 2022-02-08 | 9 | $135 | $84 | $104.777 | $73.83 | 41.92% |
| 2022-02-17 | 9 | $133 | $82 | $100.625 | $73.83 | 36.29% |
| 2022-03-01 | 10 | $133 | $71 | $97.333 | $73.83 | 31.83% |
| 2022-04-12 | 10 | $133 | $71 | $97.888 | $73.83 | 32.59% |
| 2022-04-28 | 10 | $133 | $68 | $97.555 | $73.83 | 32.13% |
| 2022-05-04 | 10 | $133 | $68 | $96.7 | $73.83 | 30.98% |
| 2022-05-18 | 10 | $152 | $65 | $100.272 | $73.83 | 35.81% |
| 2022-06-01 | 10 | $152 | $65 | $99.363 | $73.83 | 34.58% |
| 2022-06-10 | 10 | $152 | $41 | $96.909 | $73.83 | 31.26% |
| 2022-06-14 | 10 | $152 | $41 | $92.454 | $73.83 | 25.23% |
| 2022-07-27 | 12 | $152 | $40 | $86.461 | $73.83 | 17.11% |
| 2022-08-02 | 10 | $152 | $40 | $86.461 | $73.83 | 17.11% |
| 2022-08-03 | 13 | $152 | $40 | $89.642 | $73.83 | 21.42% |
| 2022-08-17 | 13 | $152 | $40 | $88.214 | $73.83 | 19.48% |
| 2022-08-18 | 13 | $152 | $40 | $87.285 | $73.83 | 18.22% |
| 2022-08-22 | 13 | $152 | $40 | $87.714 | $73.83 | 18.81% |
The Trend in the Analyst Price Target
Over the past 41 weeks, BPMC's average price target has gone down $25.51.
Over the past 41 weeks, BPMC's average upside potential has been 46.52%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-12 | 9 | 135 | 84 | 113.333 | 81.50 | 39.06% |
| 2022-04-12 | 10 | 133 | 71 | 97.888 | 67.01 | 46.08% |
| 2022-05-04 | 10 | 133 | 68 | 96.700 | 63.26 | 52.86% |
| 2022-05-04 | 10 | 133 | 68 | 97.000 | 63.26 | 53.34% |
| 2022-06-10 | 10 | 152 | 41 | 96.909 | 48.07 | 101.6% |
BPMC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.08 | 8 | 0 | 3 | 2 | 2 | 13 |
The Trend in the Broker Recommendations
BPMC's average broker recommendation rating worsened by 0.25 over the prior 14 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BLUEPRINT MEDICINES CORP's average analyst price target is greater than 2322.54% of Pharmaceutical Products stocks.
- BPMC has a higher upside potential (average analyst target price relative to current price) than 500.66% of Pharmaceutical Products stocks.
- In terms of how BLUEPRINT MEDICINES CORP fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is higher than 2149.87% of that group.
- In terms of how BLUEPRINT MEDICINES CORP fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -1917.46% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BLUEPRINT MEDICINES CORP are BBIO, AXSM, and AVIR.
View All Top Stocks by Price Target
What is the outlook for BPMC? Use POWR Ratings for clearer insight into price direction.